NEW YORK (GenomeWeb News) — Proteome Systems has licensed its Eukarion portfolio of small-molecule drug compounds to Minerva Healthcare, which is developing treatments for dermatological and other diseases, Proteome Systems said last week. 
The company also said it has appointed Jenny Harry CEO, replacing Stephen Porges. Harry has been deputy CEO since 2005.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.